Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women

NCT00888862 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder
Menopausal Staging and Vasomotor Symptoms (for Females)

Interventions

DRUG: Desvenlafaxine Succinate

Sponsor

Hamilton Health Sciences Corporation

Collaborators

[object Object]
[object Object]
[object Object]